News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
687,319 Results
Type
Article (39122)
Company Profile (282)
Press Release (647915)
Section
Business (203892)
Career Advice (1994)
Deals (35369)
Drug Delivery (89)
Drug Development (80838)
Employer Resources (168)
FDA (16096)
Job Trends (14806)
News (344617)
Policy (32449)
Tag
Academia (2530)
Alliances (49156)
Alzheimer's disease (1250)
Approvals (16032)
Artificial intelligence (143)
Bankruptcy (352)
Best Places to Work (11569)
Biotechnology (201)
Breast cancer (186)
Cancer (1323)
Cardiovascular disease (106)
Career advice (1662)
Cell therapy (269)
Clinical research (64588)
Collaboration (442)
Compensation (245)
COVID-19 (2540)
C-suite (106)
Data (1358)
Diabetes (163)
Diagnostics (6166)
Earnings (84872)
Employer resources (146)
Events (109926)
Executive appointments (364)
FDA (16725)
Funding (408)
Gene therapy (192)
GLP-1 (590)
Government (4331)
Healthcare (18683)
Infectious disease (2629)
Inflammatory bowel disease (110)
Interviews (309)
IPO (16328)
Job creations (3625)
Job search strategy (1418)
Layoffs (416)
Legal (7859)
Lung cancer (186)
Manufacturing (194)
Medical device (13205)
Medtech (13210)
Mergers & acquisitions (19172)
Metabolic disorders (431)
Neuroscience (1561)
NextGen Class of 2024 (6500)
Non-profit (4466)
Northern California (1638)
Obesity (250)
Opinion (180)
Patents (114)
People (56399)
Phase I (20085)
Phase II (28442)
Phase III (21209)
Pipeline (503)
Postmarket research (2560)
Preclinical (8541)
Radiopharmaceuticals (236)
Rare diseases (252)
Real estate (5890)
Regulatory (21623)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1422)
Startups (3562)
United States (14734)
Vaccines (560)
Weight loss (175)
Date
Last 7 days (678)
Last 30 days (2439)
Last 365 days (35222)
2024 (34424)
2023 (40076)
2022 (51173)
2021 (55712)
2020 (54087)
2019 (46541)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (713)
Arizona (194)
Asia (37228)
Australia (6077)
California (3682)
Canada (1409)
China (290)
Colorado (167)
Connecticut (170)
Europe (79734)
Florida (513)
Georgia (130)
Illinois (372)
Indiana (218)
Kansas (96)
Maryland (614)
Massachusetts (2880)
Michigan (169)
Minnesota (285)
New Jersey (1062)
New York (1047)
North Carolina (732)
Northern California (1638)
Ohio (144)
Pennsylvania (901)
South America (1091)
Southern California (1422)
Texas (530)
Utah (105)
Washington State (391)
687,319 Results for "ionpath inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Ionpath Announces Shift Toward Spatial Proteomics Services Business
Ionpath, a pioneer in high-definition spatial proteomics, announced a rebalancing of the company’s focus toward its Spatial Proteomics Services.
May 24, 2023
·
2 min read
Business
Ionpath Names Goran Pljevaljcic as Chief Commercial Officer
Ionpath, a pioneer in high-definition spatial proteomics, announced today that Goran Pljevaljcic has joined the company as its Chief Commercial Officer.
November 1, 2022
·
2 min read
Biotech Bay
Ionpath Receives Strategic Investment to Support Spatial Proteomics Innovation
Ionpath, Inc., a leader in high-definition spatial proteomics, announced that Thermo Fisher Scientific, the world leader in serving science, has made a strategic investment in the company.
May 11, 2022
·
2 min read
Biotech Bay
Ionpath Showcases Real-Time Spatial Phenotyping Using MIBI Spatial Proteomics Technology at the Annual Meeting of the Society for Immunotherapy of Cancer
Ionpath, a pioneer in high-definition spatial proteomics, today announced that the results of several studies enabled by multiplexed ion beam imaging (MIBI™) technology will be presented in posters at this week’s annual meeting of the Society for Immunotherapy of Cancer (SITC).
November 8, 2022
·
3 min read
Biotech Bay
Cell Publication Highlights Ionpath MIBI Spatial Proteomics Technology in Foundational Study Predicting Breast Cancer Progression
Ionpath, Inc., the leader in high-definition spatial proteomics, today announced that a peer-reviewed research study led by scientists at Stanford University, Washington University, Duke University, and Arizona State University has been published in the journal Cell.
January 20, 2022
·
3 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Biotech Bay
Ionpath Expands Biopharmaceutical Partnerships Program to Rapidly Deliver Novel Insights Utilizing the Company’s High-Definition Spatial Proteomics Platform
Ionpath, Inc. today announced a new program for biopharmaceutical research organizations interested in piloting spatial phenotyping analyses of tissue samples leveraging the company’s Multiplexed Ion Beam Imaging (MIBI™) technology.
August 26, 2021
·
3 min read
Press Releases
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
December 12, 2024
·
19 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
1 of 68,732
Next
